New Methodology Webinar Focuses on Supply Chain and Value Analysis

value-based care_1200-1.jpgDespite the possibility of impending changes to current healthcare regulations, it appears, at least for the moment, that value-based purchasing and bundled payment plans are here to stay. As a result, hospitals and health systems must scrutinize their decision-making processes around health technology acquisitions, product standardization, and utilization management. As part of that process, it is incumbent upon both supply chain/value analysis professionals and clinicians to consider three important questions:

  • Does the technology work?
  • Is the technology safe?
  • For which patient population does it work?

“High-quality evidence can guide supply chain professionals, working in concert with their physicians, to select the best products for care delivery while establishing a standard of care.”

Register for Webinar Here

 

weighing cost_1200.jpgIn addition to safety, efficacy, and patient populations, value analysis teams in particular must account for the cost-effectiveness of a technology. This is especially true when there is another health technology on the market with the claims of meeting the above criteria, but that comes in at a price point that is markedly higher or lower than its competitors. But how do you determine that information?

Much has been said recently of the role of evidence in healthcare. A recent essay published in ProPublica noted the significant and potentially drastic consequences of the lack of quality evidence integrated into the delivery of care. Similarly, high-quality evidence can guide supply chain professionals, working in concert with their physicians, to select the best products for care delivery while establishing a standard of care.

“But it takes time, resources, and expertise to compile, let alone analyze the full body of existing published, peer-reviewed evidence. Who has the answer? We do.”

help_1200.jpgBut it takes time, resources, and expertise to compile, let alone analyze the full body of existing published, peer-reviewed evidence. There are budgets to be met, patients who require care, and electronic health records (EHR) to manage. Not to mention that not all supply chain professionals have a clinical background, which presents an additional challenge in interpreting the literature. Who has the answer?

We do.

Register for “Making the Grade: Utilizing Evidence for Health Technology Decisions.” In our FREE webinar, we’ll address:

  • The link between health technology assessments (HTAs) and evidence-based decision-making
  • The Hayes methodology for conducting HTAs and determining the Hayes Rating
  • How to apply the Hayes Rating to health technology acquisition and utilization processes

In addition, selected participants will receive FREE access to a full report, “Comparative Effectiveness of Bupivacaine Liposome Injectable Suspension for Relief of Postoperative Pain Following Joint Arthroplasties” which will be used as a case study for the webinar.

Don’t miss this chance to get an in-depth look at a comparative effectiveness review (CER), an invaluable tool for health systems participating in bundled payment plans. The webinar take place on Thursday, March 30th. Register below today!

Register for Webinar Here

Topics: Hospitals, Hayes Blog, Health Technology Assessments,

Sign up to receive updates from our blog

Our latest articles

New Call-to-action